MASSDEVICE ON CALL — Johnson & Johnson (NYSE:JNJ) and its Ethicon subsidiary notched their 1st lawsuit since the company suspended sales of its laparoscopic power morcellators.

The devices were the subject of an FDA warning issued last month over concerns that morcellation, used to break apart uterine tissue or fibroids so that they can be removed through a small incision, may accidentally cause the spread of undetected cancers.

Plaintiffs Brenda Leuzzi and George Leuzzi this week sued Ethicon in a New York federal court, claiming that Brenda was diagnosed with cancer after receiving morcellation during a robot-assisted hysterectomy in 2012, Law360.com reported. The lawsuit accuses Ethicon of substandard testing of its Morcelex morcellation device.

Fellow medtech titan Boston Scientific (NYSE:BSX) last night announced the $65 million acquisition of IoGyn, a company with an FDA-approved medical device that’s an alternative to morcellation for removing uterine tissue.

 Weight Watchers gets into digital health
Weight Watchers revealed this week that it’s getting into digital health tracking with the acquisition of  Wello, a Silicon Valley weight-loss and fitness tracker startup.
Read more

 Vibrating pill helps relieve constipation
Israeli researchers released promising results from a clinical study of the Vibrant ingestible pill that vibrates to relieve constipation through mechanical stimulation as it passes through the body.  
Read more

 Cook Medical celebrates the 25th anniversary of lead extraction
Cook Medical touted the 25th anniversary of the company’s invention of cardiac lead extraction technology with the launch of its Lead Extraction At 25 website.
Read more

 Boston Scientific signs up for colon cancer screening initiative
Boston Scientific (NYSE:BSX) joined forces with the Colon Cancer Alliance to promote awareness and screening for colon cancer.
Read more